Brian K Rhees

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in DNA Sequencing. Top assignees: Verinata Health, Inc., Echelon Diagnostics, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian K Rhees. Retrieved from https://idiyas.com/inventor/brian-k-rhees

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 212(Granted Patents)

Location History:

Tracy, CA (US) (2014 - 2021)
Gilbert, AZ (US) (2015 - 2024)
Chandler, AZ (US) (2016 - 2024)

Company Filing History:

17 out of 57

Verinata Health, Inc.

patents

1 out of 3

Echelon Diagnostics, Inc.

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Copy Number Variation

DNA Sequencing

Prenatal Diagnosis

Cancer Detection

Polymorphism Counts

Count Bias Correction

Genome Fractions

Massively Parallel Sequencing

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12553084 - Method for determining copy number variations (2026-02-17),

2. 12522869 - SEQUENCING METHODS AND COMPOSITIONS FOR PRENATAL DIAGNOSES (2026-01-13),

3. 11884975 - Sequencing methods and compositions for prenatal diagnoses (2024-01-30),

4. 11875899 - Analyzing copy number variation in the detection of cancer (2024-01-16),

5. 11697846 - Detecting and classifying copy number variation (2023-07-11),

6. 11332774 - Method for determining copy number variations (2022-05-17),

7. 11286520 - Method for determining copy number variations (2022-03-29),

8. 11127485 - Techniques for fine grained correction of count bias in massively parallel DNA sequencing (2021-09-21),

9. 10941442 - Sequencing methods and compositions for prenatal diagnoses (2021-03-09),

10. 10658070 - Resolving genome fractions using polymorphism counts (2020-05-19),

11. 10482993 - Analyzing copy number variation in the detection of cancer (2019-11-19),

12. 10415089 - Detecting and classifying copy number variation (2019-09-17),

13. 10388403 - Analyzing copy number variation in the detection of cancer (2019-08-20),

14. 9657342 - Sequencing methods for prenatal diagnoses (2017-05-23),

15. 9447453 - Resolving genome fractions using polymorphism counts (2016-09-20),

Title: Innovations in Prenatal Diagnostics and Cancer Detection by Brian K. Rhees

Introduction

Brian K. Rhees, an accomplished inventor based in Gilbert, AZ, holds an impressive portfolio of 16 patents. His work significantly advances the fields of prenatal diagnostics and cancer detection, providing innovative solutions that enhance medical analysis and patient care.

Latest Patents

Among Rhees's latest innovations, two notable patents stand out. The first is related to sequencing methods and compositions for prenatal diagnoses. This invention offers a protocol for determining aneuploidy and fetal fraction in maternal samples containing both fetal and maternal cell-free DNA (cfDNA) through massively parallel sequencing. The method introduces a novel library preparation protocol that improves the quality of DNA libraries while expediting analysis for prenatal diagnostics.

The second patent concerns analyzing copy number variation (CNV) in cancer detection. This invention presents a novel statistical approach to determine CNVs of a sequence of interest within a mixed nucleic acid sample. It effectively addresses variability that can arise from various processes and is applicable to a range of medical conditions, including fetal aneuploidies and chromosomal variations linked to different health issues.

Career Highlights

Throughout his career, Brian K. Rhees has made significant contributions to medical technology. He has worked with esteemed organizations such as Verinata Health, Inc. and Echelon Diagnostics, Inc., where he honed his skills in developing innovative solutions in genetic testing and diagnostics.

Collaborations

Rhees has collaborated with notable professionals in his field, including Richard P. Rava and John P. Burke. Together, they have contributed to advancing diagnostic methodologies and improving healthcare outcomes through their innovative efforts.

Conclusion

Brian K. Rhees exemplifies innovation in the medical field through his patents that focus on prenatal diagnoses and cancer detection. His contributions not only enhance the scientific community's understanding of genetic conditions but also pave the way for better patient care through advanced diagnostic techniques.

Profile summary based on public USPTO records.